earnings
DN
NASDAQ · DNLI
Denali Therapeutics Inc.
Healthcare · Biotechnology
$21.09
Down-$0.31 (-1.45%)
Updated Sep 13, 2026, 11:06 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.55B
- P/E ratio
- -6
- Dividend yield
- 0.00%
- 52-week range
- $12.58 – $27.30
- Volume
- 1.24M
- Avg. volume
- 1.72M
Price performance
DNLI price history
1M range · 19 trading sessions · Daily adjusted prices
DNLI closed at $21.09 after 19 trading sessions, down 13.39% for the selected period.
- Last close
- $21.09
- Period change
- -13.39%
- Period low
- $21.09
- Period high
- $25.69
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $21.648 | $21.7916 | $21.055 | $21.09 | 1.24M |
| Sep 10, 2026 | $21.24 | $21.58 | $21.09 | $21.40 | 938.56K |
| Sep 9, 2026 | $21.69 | $22.06 | $21.34 | $21.57 | 2.09M |
| Sep 8, 2026 | $21.79 | $22.25 | $21.66 | $22.08 | 1.65M |
| Sep 4, 2026 | $22.32 | $22.4754 | $22.145 | $22.28 | 799.63K |
| Sep 3, 2026 | $23.00 | $23.025 | $22.35 | $22.80 | 1.73M |
| Sep 2, 2026 | $23.33 | $23.86 | $22.53 | $22.85 | 1.77M |
| Sep 1, 2026 | $23.44 | $23.75 | $23.06 | $23.265 | 1.43M |
| Aug 31, 2026 | $23.72 | $24.01 | $23.4108 | $23.76 | 985.86K |
| Aug 28, 2026 | $24.42 | $24.615 | $23.92 | $24.00 | 807.6K |
| Aug 27, 2026 | $24.43 | $24.74 | $24.16 | $24.67 | 700.11K |
| Aug 26, 2026 | $24.75 | $24.89 | $24.33 | $24.57 | 771.27K |
| Aug 25, 2026 | $24.86 | $25.26 | $24.81 | $24.93 | 1.12M |
| Aug 24, 2026 | $24.88 | $25.2683 | $23.41 | $24.20 | 1.32M |
| Aug 21, 2026 | $25.25 | $25.37 | $24.60 | $24.92 | 680.99K |
| Aug 20, 2026 | $25.15 | $25.6031 | $24.65 | $24.95 | 976.85K |
| Aug 19, 2026 | $25.00 | $25.70 | $24.61 | $25.69 | 1.15M |
| Aug 18, 2026 | $24.17 | $24.49 | $24.01 | $24.31 | 1.1M |
| Aug 17, 2026 | $24.29 | $24.66 | $24.11 | $24.35 | 1M |
Latest DNLI news
The latest Smart Investors Daily articles mentioning DNLI.
Stock researchResearch & News · Analysis
Loading stock research…